Clinical Trial Update: Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing intravitreal corticosteroid therapy with anti-VEGF treatment for diabetic macular edema prior to cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Diabetic Macular Edema

Drugs mentioned

• Anti-VEGF therapy (class) (anti-VEGF agent)
• Intravitreal corticosteroid (class) (intravitreal corticosteroid)

Snippet

Sponsor: Bay Area Retina Associates | Conditions: Diabetic Macular Edema, Cataract | Phase 4 | Status: COMPLETED